Us Bancorp \De\ Aadi Bioscience, Inc. Transaction History
Us Bancorp \De\
- $75.6 Billion
- Q4 2024
A detailed history of Us Bancorp \De\ transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 3,333 shares of AADI stock, worth $8,532. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,333
Previous 3,333
-0.0%
Holding current value
$8,532
Previous $6,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding AADI
# of Institutions
57Shares Held
15.6MCall Options Held
15KPut Options Held
3.1K-
Avoro Capital Advisors LLC New York, NY2.85MShares$7.29 Million0.13% of portfolio
-
Qvt Financial LP New York, NY2.31MShares$5.92 Million0.72% of portfolio
-
Bml Capital Management, LLC Zionsville, IN2.1MShares$5.38 Million4.12% of portfolio
-
Acuta Capital Partners, LLC Belmont, CA1.85MShares$4.73 Million8.31% of portfolio
-
Acorn Capital Advisors, LLC New York, NY1.15MShares$2.94 Million1.96% of portfolio
About Aadi Bioscience, Inc.
- Ticker AADI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,016,800
- Market Cap $53.8M
- Description
- Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...